SpeechDx Featured in Alzheimer's & Dementia Journal for AI Speech Marker Research

Jun 23, 2026
A paper in Alzheimer's & Dementia highlights SpeechDx's role in developing AI tools that use speech patterns to detect early cognitive decline and support personalized Alzheimer's care.

SpeechDx was featured in a new paper published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association, announced in a press release. The publication explores how artificial intelligence and digital speech-based markers are being used to advance early detection and monitoring of Alzheimer's disease.

The paper outlines how scalable digital biomarkers can help identify cognitive changes before clinical symptoms appear. It also highlights the SpeechDx initiative, which collects longitudinal speech data to support the creation of tools for predicting cognitive decline and enabling earlier intervention.

According to the release, SpeechDx aims to accelerate the development of digital markers that guide more personalized care and improve the ability to assess Alzheimer's risk in its earliest stages.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.